Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Asan Medical center

     
Seoul , Songpa-gu 138-736
Republic of Korea

 

Principal Investigator:
Prof. Yoon-Koo Kang
Contact:
MoYoul Beck +82 2 3010 6110 beckmy@amc.seoul.kr
Activation Status of this Site:
Closed
Notes about this Site:
Asan Medical center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.